Insights & Resources | Pfizer CentreOne

Your Questions Answered - Technology Transfer in Sterile Injectables

Pfizer CentreOne’s sterile injectables experts answer your questions following our recent webinar on the three phases of a technology transfer on a sterile injectable project.

Webinar | Technology Transfer in Sterile Injectables - Three Phases Towards Success

Pfizer CentreOne’s sterile injectables experts discuss the three phases of a technology transfer on a sterile injectable project, covering how to bridge information gaps and facilitate the path to successful regulatory filing at this fundamental stage of drug development.

Pfizer CentreOne Newsletter January 2021 Edition

At Pfizer CentreOne, we are proud of the trust you placed in our organization, whether it’s for securing your API or intermediates supply, or developing and commercializing your products. Together with you, we draw inspiration from our purpose to help patients in need, and that has never been more important than it is now.

The Power of People: What I Learned About My Team

The foundation of any great team is the strong connection among its members. I started my role as the GM of Pfizer CentreOne during the pandemic and was concerned about establishing relationships virtually. Two months later, I have yet to meet any of my team members face-to-face. However, the connections I’ve already made across the team are strong and they have made quite the impression.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Harnessing the power of virtual audits to keep regulatory compliance front and center in 2020

It’s been over 12 months since the COVID-19 pandemic led to changes in the way businesses and the economy operate. Due to the various quarantine measures that had been implemented at sites to comply with local, state, and national restrictions, in-person audits could not be conducted. Therefore, it was vital to find innovative solutions to demonstrate our compliance commitment to our customers. Our active pharmaceutical ingredient (API) manufacturing facility in Kalamazoo, MI, came up with an innovative solution.

Andrew Moore named in The Medicine Maker's 2021 Power List

Our General Manager, Andrew Moore, has been named as one of the top 20 most influential industry leaders in small molecules on The Medicine Maker's 2021 Power List.

Experience the Art of Science - Gillian Kidd's story

In our latest ‘Experience the Art of Science’ blog post, we meet Gillian Kidd, Technology Specialist at our Newbridge facility and a clarinet player.

How successful CDMO collaboration sets the foundation for sterile injectable product success

Pfizer CentreOne’s sterile injectables experts discuss how a small or medium sized biotech or pharma company can benefit from the experience and assistance provided by a CDMO for their sterile injectable project.

Why culture is more than just a “nice-to-have” at Pfizer CentreOne

What does a CDMO’s goal to create a great workplace culture have to do with delivering great drug products for pharma companies? Andrew Moore, General Manager at Pfizer CentreOne discusses what a good workplace culture means to him.

Experience the Art of Science - Stefano Petracci's story

In our latest ‘Experience the Art of Science’ blog post, we meet Stefano Petracci, Technical Project Manager at our Ascoli facility and an accomplished artist.